abstract |
The present disclosure provides a pharmaceutical composition for the nitrate group comprising an N -substituted hydroxylamine derivative. These compositions are highly effective for the treatment of cardiovascular diseases such as heart failure, have suitable toxicological characteristics, and are sufficiently stable for intravenous or oral administration. |